BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11549775)

  • 1. The thrombophilic state in cancer patients.
    Gouin-Thibault I; Achkar A; Samama MM
    Acta Haematol; 2001; 106(1-2):33-42. PubMed ID: 11549775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis of the thrombophilic state in cancer patients.
    Gouin-Thibault I; Samama MM
    Semin Thromb Hemost; 1999; 25(2):167-72. PubMed ID: 10357084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilia in cancer.
    Falanga A
    Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired thrombophilic syndromes.
    Matei D; Brenner B; Marder VJ
    Blood Rev; 2001 Mar; 15(1):31-48. PubMed ID: 11333137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
    van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Venous thrombosis and cancer].
    Gouin-Thibaut I; Samama MM
    Ann Biol Clin (Paris); 2000; 58(6):675-82. PubMed ID: 11098164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay.
    Curnow JL; Morel-Kopp MC; Roddie C; Aboud M; Ward CM
    J Thromb Haemost; 2007 Mar; 5(3):528-34. PubMed ID: 17166248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer and hypercoagulability.
    Kawai K; Watanabe T
    Surg Today; 2014 May; 44(5):797-803. PubMed ID: 23670036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of the thrombophilic state in the cancer patient.
    Falanga A; Rickles FR
    Semin Thromb Hemost; 1999; 25(2):173-82. PubMed ID: 10357085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
    Pineda J; Marín F; Marco P; Roldán V; Valencia J; Ruiz-Nodar JM; Sogorb F; Lip GY
    Int J Cardiol; 2009 Aug; 136(2):222-5. PubMed ID: 18625524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
    Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
    Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic approach to hypercoagulable states.
    Remkova A
    Bratisl Lek Listy; 2006; 107(8):292-5. PubMed ID: 17125064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on tumor cell procoagulant factors.
    Gale AJ; Gordon SG
    Acta Haematol; 2001; 106(1-2):25-32. PubMed ID: 11549774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of thrombosis by hemostatic markers].
    Wada H; Matsumoto T; Yamashita Y
    Nihon Rinsho; 2014 Jul; 72(7):1232-6. PubMed ID: 25163313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia in patients with chronic immune thrombocytopenia.
    Wong RS; Bakshi K; Brainsky A
    Scand J Clin Lab Invest; 2015 Jan; 75(1):13-7. PubMed ID: 25296772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.